Інструкція із застосування ROKIINSA
Зміст інструкції
Rhokiinsa 200 micrograms/mL eye drops, solution
netarsudil
Read this leaflet carefully before you start using this medicine as it contains important
information for you.
- Keep this leaflet. You may need to read it again.
- If you have any questions, ask your doctor or pharmacist.
- This medicine has been prescribed for you only. Do not pass it on to others, even if they have the same symptoms as you, as it may be harmful.
- If you get any side effects, even those not listed in this leaflet, tell your doctor or pharmacist. See section 4.
Contents of this leaflet
- 1. What Rhokiinsa is and what it is used for
- 2. What you need to know before you use Rhokiinsa
- 3. How to use Rhokiinsa
- 4. Possible side effects
- 5. How to store Rhokiinsa
- 6. Contents of the pack and other information
1. What is Rhokiinsa and what is it used for
Rhokiinsa contains an active substance called netarsudil. Netarsudil belongs to a group of
medicines called "Rho-kinase inhibitors" whose function is to reduce the amount of
fluid inside the eye and therefore lower its pressure.
Rhokiinsa is indicated to lower eye pressure in adults suffering from an eye condition
known as glaucoma or who have increased intraocular pressure. If the intraocular pressure is too high it can damage vision.
2. What you need to know before using Rhokiinsa
Do not use Rhokiinsa
- if you are allergic to netarsudil or any of the other ingredients of this medicine (listed in section 6).
Warnings and precautions
- Do not use Rhokiinsa more than once a day, as this may result in more undesirable effects.
Children and adolescents
Rhokiinsa should not be used in children and adolescents under 18 years of age, as it has
only been studied in adults.
Other medicines and Rhokiinsa
Tell your doctor or pharmacist if you are taking, have recently taken or might take any other
medicines (see section 3 “How to use Rhokiinsa”).
Pregnancy and breastfeeding
If you are pregnant, suspect you may be pregnant or are planning a pregnancy, or if you are breastfeeding,
ask your doctor or pharmacist for advice before taking this medicine. Do not use
Rhokiinsa if you are pregnant or breastfeeding unless your doctor advises you to do so.
Driving and using machines
Rhokiinsa has a negligible effect on the ability to drive and use machines. You may
notice blurred or abnormal vision shortly after using Rhokiinsa. Do not drive or use
machines until these symptoms have disappeared.
Rhokiinsa contains benzalkonium chloride
This medicine contains approximately 150 micrograms of benzalkonium chloride in each mL of
solution.
Benzalkonium chloride can be absorbed by soft contact lenses and change their colour. You should
remove your contact lenses before using this medicine and reinsert them after 15 minutes (see
section 3 “How to use Rhokiinsa”).
Benzalkonium chloride can also cause eye irritation, especially if you have dry eyes or
corneal abnormalities (the clear layer at the front of the eye). Contact your doctor if
you experience abnormal eye sensitivity or more or less stinging eye pain after using
this medicine.
3. How to use Rhokiinsa
Use this medicine following exactly the instructions of your doctor or pharmacist. If you have
doubts, consult your doctor or pharmacist.
Use Rhokiinsa only for the eyes (ophthalmic use). Do not ingest or inject it.
The recommended dose is one drop in the affected eye(s) once a day in the evening. Use the
medicine every day at approximately the same time.
Do not use more than one drop once a day in the affected eye(s).
How to use

- Wash your hands before starting. Contact lenses must be removed before instilling Rhokiinsa (see section 2 “Rhokiinsa contains benzalkonium chloride”).
- Do not touch the dropper with your fingers when opening or closing the bottle. This could contaminate the eye drops.
- Unscrew the bottle cap and place the cap aside on a clean surface. Continue to hold the bottle, ensuring that the dropper tip does not come into contact with anything.
- Hold the bottle between your thumb and fingers, pointing downwards.
- Tilt your head back.
- Pull down your lower eyelid with a clean finger to form a "pocket" between the eyelid and the eye. The drop should be placed there (figure 1).
- Bring the dropper tip close to the eye. It may be helpful to use a mirror.
- Do not touch the eye, eyelid, surrounding areas, or other surfaces with the dropper tip. This could contaminate the eye drops.
- Gently press the bottle to release one drop of Rhokiinsa into the eye.
- Put only one drop in the eye each time. If the drop does not enter the eye, repeat the operation.
- If you need to use the eye drops in both eyes, repeat the steps for the other eye while the bottle is open.
- Replace the bottle cap to close it.
If you are using other eye drops, wait at least five minutes after using them, then use Rhokiinsa
last due to the vasodilating properties of netarsudil. If you are using ophthalmic ointments, these
must be used last.
If you use more Rhokiinsa than you should
Rinse the eye with lukewarm water. Do not put in any more drops until the time of your next
regular dose.
If you forget to use Rhokiinsa
Continue with the next dose as scheduled. Do not use a double dose to make up for a
missed dose.
If you stop using Rhokiinsa
Do not stop using Rhokiinsa without first talking to your doctor. If you stop using
Rhokiinsa, your eye pressure will not be controlled and this could lead to loss of vision.
If you have any questions about using this medicine, ask your doctor or pharmacist.
4. Possible side effects
Like all medicines, this medicine can cause side effects, although not everybody gets them.
The following non-serious side effects have been observed with Rhokiinsa:
Very commonside effects (may affect more than 1 in 10 people)
- Effects on the eye: eye redness; fine deposits in the front part of the eye (verticillated cornea); pain where the drops were instilled
Commonside effects (may affect up to 1 in 10 people)
- Effects on the eye: eye infection or inflammation; dry eye or small breaks in the tear film on the surface of the eye (conjunctivitis, punctate keratitis); eye inflammation caused by an allergic reaction or prominent blood vessels; eye discharge; eyes may become watery; eye pain; feeling of grittiness or having something in the eyes; general eye redness shortly after putting the drops in; spots or patches of eye redness; itchy eyelids; swelling around the eye; blurred vision and slightly reduced vision; sensitivity to light; blurred vision
- General side effects: headache
Uncommonside effects (may affect up to 1 in 100 people)
- Effects on the eye: increased pressure of the fluid inside the eye; inflammation of the colored part of the eye (iris); bulging of the iris; small colored spots on the surface of the eye; growth of eyelashes; loss of eyelashes (madarosis); dry eyelids; abnormal rotation outwards of the lower eyelid; dry eye caused by inflammation of the eyelid glands; crusting of the eyelids; oculopathy related to diabetes (diabetic retinopathy); excess folds of the conjunctiva (conjunctivochalasis); blindness; blurred, double and haloed vision; cataract; eye allergy; glassy eyes; fatigue
- General side effects: increased allergy symptoms; dizziness; discomfort and pain in the nose
- Skin effects: redness or itchy skin; rash; inflammation of the cartilage; skin abrasion
Reporting of side effects
If you get any side effects, even those not listed in this leaflet, please tell your doctor or pharmacist. You can also report side effects directly through the national reporting system listed in Annex V. By reporting side effects you can help provide more information on the safety of this medicine.
5. How to store Rhokiinsa
Keep this medicine out of the sight and reach of children.
Do not use this medicine after the expiry date which is stated on the package and on the label of the
vial after Exp. The expiry date refers to the last day of that month.
Unopened vials: store in a refrigerator (2 °C – 8 °C).
After opening the vial: do not store at a temperature above 25 °C.
Do not use the vial 4 weeks after first opening to prevent infections and use a new vial.
Do not dispose of any medicine in wastewater or household waste. Ask your pharmacist how to
dispose of medicines you no longer use. This will help protect the environment.
6. Contents of the pack and other information
What Rhokiinsa contains
- The active ingredient is netarsudil. Each mL of solution contains 200 micrograms of netarsudil (as mesilate).
- The other excipients are benzalkonium chloride (see section 2 "Rhokiinsa contains benzalkonium chloride"), mannitol, boric acid, sodium hydroxide (for pH adjustment) and water for injections.
Description of the appearance of Rhokiinsa and contents of the pack
Rhokiinsa 200 micrograms/mL eye drops, solution is a clear solution in a plastic bottle.
Each bottle contains 2.5 mL of medicine and each pack contains one bottle with a screw cap.
Marketing authorisation holder
Santen Oy
Niittyhaankatu 20,
33720 Tampere,
Finland
Manufacturer
Santen Oy
Kelloportinkatu 1,
33100 Tampere,
Finland
For further information on this medicinal product, contact the local representative of the marketing
authorisation holder:
België/Belgique/Belgien
Santen Oy
Lietuva
Santen Oy
Tel: +370 37 366628
България
Santen Oy
Teл.: +40 21 528 0290
Tél/Tel: +32 (0) 24019172
Luxembourg/Luxemburg
Santen Oy
Tél/Tel: +352 (0) 27862006
Česká republika
Santen Oy
Tel: +358 (0) 3 284 8111
Magyarország
Santen Oy
Tel: +358 (0) 3 284 8111
Danmark
Santen Oy
Tlf: +45 898 713 35
Malta
Santen Oy
Tel: +358 (0) 3 284 8111
Deutschland
Santen GmbH
Tel: +49 (0) 3030809610
Nederland
Santen Oy
Tel: +31 (0) 207139206
Eesti
Santen Oy
Tel: +372 5067559
Norge
Santen Oy
Tlf: +47 21939612
Ελλάδα
Santen Oy
Τηλ: +358 (0) 3 284 8111
Österreich
Santen Oy
Tel: +43 (0) 720116199
España
Santen Pharmaceutical Spain S.L.
Tel: +34 914 142 485
Polska
Santen Oy
Tel.: +48(0) 221042096
France
Santen S.A.S.
Tél: +33 (0) 1 70 75 26 84
Portugal
Santen Oy
Tel: +351 308 805 912
Hrvatska
Santen Oy
Tel: +358 (0) 3 284 8111
Ireland
Santen Oy
România
Santen Oy
Tel: +358 (0) 3 284 8111
Slovenija
Santen Oy
Tel: +353 (0) 16950008 Tel: +358 (0) 3 284 8111
Ísland
Santen Oy
Sími: +358 (0) 3 284 8111
Slovenská republika
Santen Oy
Tel: +358 (0) 3 284 8111
Italia
Santen Italy S.r.l.
Tel: +39 0236009983
Suomi/Finland
Santen Oy
Puh/Tel: +358 (0) 974790211
Κύπρος
Santen Oy
Τηλ: +358 (0) 3 284 8111
Sverige
Santen Oy
Tel: +46 (0) 850598833
United Kingdom (Northern Ireland)
Santen Oy
Tel: +353 (0) 169 500 08
(UK Tel: + 44 (0) 345 075 4863)
Other sources of information
More detailed information on this medicinal product is available on the website of the European
Medicines Agency, https://www.ema.europa.eu .
Latvija
Santen Oy
Tel: +371 677 917 80
- Країна реєстрації
- Лікарська формаEye drops, solution, 200 MCG / ML
- Код АТХS01EX05
- Діюча речовина
- Потрібен рецептТак
- Виробник
- Ця інформація надана лише для ознайомлення і не є медичною порадою. Рішення щодо лікування завжди приймає лікар.
- Альтернативи до ROKIINSAЛікарська форма: Eye drops, powder and solvent for solution, 0,5%Діюча речовина: dapiprazoleВиробник: OMNIVISION ITALIA SRLПотрібен рецептЛікарська форма: Eye drops, solution, 40 MCG/MLДіюча речовина: травопростВиробник: FIDIA FARMACEUTICI S.P.A.Потрібен рецептЛікарська форма: Eye drops, suspension, 10 MG/MLДіюча речовина: бринзоламидВиробник: OMNIVISION ITALIA SRLРецепт не потрібен
Лікарі онлайн щодо ROKIINSA
Застосування, безпека та можливість призначення рецепта — за результатами медичної оцінки.
Отримайте рецепт на ROKIINSA онлайн
Заповніть форму за 2 хвилини
Розкажіть про симптоми, історію хвороби та потрібний препарат.
Оберіть лікаря або ми призначимо
Оберіть спеціаліста або ми підберемо найближчого доступного лікаря.
Лікар розглядає ваш випадок
Зазвичай протягом 30 хвилин. Може ставити уточнювальні запитання в чаті.
Отримайте в будь-якій аптеці
Електронний рецепт надсилається на вашу пошту — дійсний по всій Польщі.
Часті запитання
ROKIINSA потребує рецепта в Італія. Ви можете обговорити з лікарем онлайн, чи підходить цей лікарський засіб для вашої ситуації.
Діюча речовина у ROKIINSA — netarsudil. Це допомагає визначити препарати з тим самим складом, але під іншими торговими назвами.
ROKIINSA виробляється компанією SANTEN OY. Назва бренду та упаковка можуть відрізнятися залежно від дистрибʼютора.
Лікарі, зокрема Сімейні лікарі, Психіатри, Дерматологи, Кардіологи, Ендокринологи, Гастроентерологи, Пульмонологи, Нефрологи, Ревматологи, Гематологи, Інфекціоністи, Алергологи, Геріатри, Педіатри, Онкологи, можуть оцінити доцільність застосування ROKIINSA з урахуванням вашого стану та місцевих правил. Ви можете записатися на онлайн-консультацію, щоб обговорити симптоми та можливі подальші кроки.
Польща має добре розвинену систему охорони здоров'я у великих містах, таких як Варшава, Краків, Вроцлав і Гданськ. Аптеки широко доступні та працюють відповідно до чинного законодавства, забезпечуючи доступ до рецептурних препаратів.
Ви можете придбати ROKIINSA у Варшаві, Кракові, Вроцлаві або Гданську в будь-якій аптеці за наявності дійсного рецепта.
Щоб отримати рецепт, ви можете скористатися Oladoctor:
Інші препарати з тією самою діючою речовиною (netarsudil) включають LAMIDOLO, AKAMBA, AIKISI. Вони можуть відрізнятися торговою назвою або формою випуску, але містять той самий терапевтичний компонент. Перед зміною або початком прийому нового препарату варто проконсультуватися з лікарем.
















